Unaltered Oxytocin and Vasopressin Plasma Levels in Patients with Schizophrenia After 4 Months of Daily Treatment with Intranasal Oxytocin
Marta Busnelli(National Research Council), Bice Chini(Neuroscience Institute), Jessica Dagani(University of Brescia), Stefano Pini(University of Pisa), Matteo Balestrieri(University of Udine), Paolo Scocco(AULSS 2 Marca Trevigiana), Francesco M. Saviotti(Casa di Cura Villa Garda), Davide Sisti(University of Urbino), Marco Rocchi(University of Urbino), Giovanni de Girolamo(Centro San Giovanni di Dio Fatebenefratelli)
Cited by 18
Related Papers
Posttraumatic stress disorder in the World Mental Health Surveys
|Psychological Medicine|2017|1.4k
The Prevalence and Correlates of Binge Eating Disorder in the World Health Organization World Mental Health Surveys
|Biological Psychiatry|2013|1.3k
Barriers to mental health treatment: results from the WHO World Mental Health surveys
|Psychological Medicine|2013|1.3k
The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys
|ADHD Attention Deficit and Hyperactivity Disorders|2016|813
Anxious and non-anxious major depressive disorder in the World Health Organization World Mental Health Surveys
|Epidemiology and Psychiatric Sciences|2015|626